What is the target ferritin (iron storage protein) level for managing restless leg syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ferritin Goal for Restless Leg Syndrome

The target serum ferritin level for managing RLS is ≤75 ng/mL or transferrin saturation <20% to initiate iron supplementation, with an optimal goal of achieving ferritin levels above 75-100 ng/mL for symptom control. 1, 2

Iron Status Assessment

  • Check serum ferritin and transferrin saturation in all patients with clinically significant RLS, ideally in the morning after avoiding iron-containing supplements and foods for at least 24 hours prior to blood draw 1, 2
  • RLS requires higher ferritin thresholds than the general population because brain iron deficiency plays a key role in pathophysiology, even when serum iron appears normal 2, 3
  • CSF studies demonstrate that patients with RLS have significantly lower CSF ferritin (1.11 ng/mL versus 3.50 ng/mL in controls) despite normal serum ferritin, confirming central nervous system iron deficiency 3

Treatment Algorithm Based on Ferritin Levels

For ferritin ≤75 ng/mL or transferrin saturation <20%:

  • Initiate oral iron (ferrous sulfate 65 mg elemental iron) or IV ferric carboxymaltose (1000 mg) as first-line treatment 1, 4
  • Oral iron is conditionally recommended with moderate certainty of evidence 1, 2
  • IV ferric carboxymaltose is strongly recommended with moderate certainty of evidence 1, 2

For ferritin 75-100 ng/mL:

  • Use IV iron formulations only (not oral iron) 1, 4
  • Oral iron absorption is poor in this range and will have minimal effect on RLS improvement 4, 5
  • IV iron can improve RLS symptoms even at ferritin levels between 75-100 ng/mL 5

For ferritin >100 ng/mL:

  • Iron supplementation is generally not indicated based on current evidence 4

Pediatric Considerations

  • In children with RLS, initiate iron supplementation if serum ferritin <50 ng/mL with oral or IV formulations 1, 2

Critical Pitfalls to Avoid

  • Do not use general population ferritin cutoffs (<15-30 ng/mL) for RLS management, as these are far too low for neurological function 4
  • Be aware that ferritin assays differ significantly between manufacturers (Beckman versus Roche methods can vary by 60% at the 75 ng/mL threshold), so use transferrin saturation as an additional parameter 6
  • The Roche method yields approximately 60% higher values than Beckman at the 75 ng/mL cutoff (121 ng/mL Roche equivalent), requiring adjustment of treatment thresholds based on your laboratory's assay 6
  • Do not test iron studies while patients are taking supplements; wait at least 24 hours after the last iron-containing product 1, 4

Evidence for Higher Ferritin Targets

  • A randomized controlled trial demonstrated that ferric carboxymaltose (1000 mg IV) significantly improved RLS severity scores by week 12 in patients with ferritin <75 μg/L or ferritin 75-300 μg/L with transferrin saturation <20% 7
  • Oral iron therapy in patients with low-normal ferritin (mean 40.6 ng/mL) showed statistically significant improvement in RLS symptoms after 12 weeks compared to placebo 8
  • These guidelines differ substantially from general population iron supplementation recommendations because RLS pathophysiology involves central dopaminergic dysfunction related to brain iron deficiency 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Restless Legs Syndrome (RLS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Iron Supplementation for Restless Legs Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Serum ferritin measurements differ according to the assay used: implications for iron therapy in restless legs syndrome.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2025

Research

Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial.

Movement disorders : official journal of the Movement Disorder Society, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.